Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults
Status:
Completed
Trial end date:
2020-04-06
Target enrollment:
Participant gender:
Summary
A single-blinded, placebo- and active-controlled, parallel, single-ascending dose phase 1
clinical trial to evaluate the safety and pharmacokinetics of DA-5207 transdermal delivery
system in healthy adults